Log on / register
Feedback | Support | My details
Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.
Rauktys A, Lee N, Lee L, Dabora SL
BMC Dermatol 2008, 8:1
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL
BMC Pharmacology 2009, 9:8 (15 April 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.